ASCVD risk reduction for patients with high Lp(a) in 2020: is there a role for PCSK9 inhibition?
29 August 2020 (13:20 - 13:35)
Organised by:
About the speaker
Kirklin Clinic, Birmingham (United States of America)
4 More presentations in this session
Professor P. Kamstrup (Copenhagen, DK)
Professor S. Tsimikas (La Jolla, US)
Access the full session
The Event
ESC Congress 2020
29 August 2020
13:20 CET
